Next Article in Journal
Immunization with a Prefusion SARS-CoV-2 Spike Protein Vaccine (RBMRNA-176) Protects against Viral Challenge in Mice and Nonhuman Primates
Next Article in Special Issue
Factors of COVID-19 Vaccination among Hong Kong Chinese Men Who Have Sex with Men during Months 5–8 since the Vaccine Rollout—General Factors and Factors Specific to This Population
Previous Article in Journal
Relationship between Anti-Spike Antibodies and Risk of SARS-CoV-2 Infection in Infants Born to COVID-19 Vaccinated Mothers
Previous Article in Special Issue
Determining the Prevalence and Correlates of COVID-19 Booster Vaccine Hesitancy in the Singapore Population Following the Completion of the Primary Vaccination Series
 
 
Article

Article Versions Notes

Vaccines 2022, 10(10), 1697; https://doi.org/10.3390/vaccines10101697
Action Date Notes Link
article pdf uploaded. 11 October 2022 15:12 CEST Version of Record https://www.mdpi.com/2076-393X/10/10/1697/pdf-vor
article xml file uploaded 12 October 2022 11:43 CEST Original file -
article xml uploaded. 12 October 2022 11:43 CEST Update https://www.mdpi.com/2076-393X/10/10/1697/xml
article pdf uploaded. 12 October 2022 11:43 CEST Updated version of record https://www.mdpi.com/2076-393X/10/10/1697/pdf
article html file updated 12 October 2022 11:44 CEST Original file -
article html file updated 13 October 2022 10:05 CEST Update -
article html file updated 1 March 2023 20:52 CET Update https://www.mdpi.com/2076-393X/10/10/1697/html
Back to TopTop